Prostatic Neoplasms Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
Active, not recruiting
  • Prostatic Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    M
    Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
    Recruiting
    • Prostatic Neoplasms
    • Pembrolizumab
    • +2 more
    • Mobile, Alabama
    • +257 more
    2022-04-07
    Apr 7, 2022
    N
    The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
    Recruiting
    • Prostatic Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
    Enrolling by invitation
    • Metastatic Prostate Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Men at High Genetic Risk for Prostate Cancer
    Recruiting
    • Prostatic Neoplasms
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 - 2022
      Completed
      • Prostatic Neoplasms
      • +4 more
      • ME TARP vaccine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      N
      Collection of Blood From Patients With Prostate Cancer
      Recruiting
      • Cancer Of Prostate
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-04-07
        Apr 7, 2022
        I
        Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.
        Recruiting
        • Prostatic Neoplasms
        • Biopsy & Imaging
        • Coventry, United Kingdom
        • +5 more
        2022-03-29
        Mar 29, 2022
        M
        Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension
        Recruiting
        • Prostatic Neoplasms
        • Pembrolizumab
        • +4 more
        • Hefei, Anhui, China
        • +19 more
        2022-04-06
        Apr 6, 2022
        E
        A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
        Not yet recruiting
        • Prostatic Neoplasms
        • +16 more
        • Birmingham, Alabama
        • +233 more
        2022-03-28
        Mar 28, 2022
        R
        Gallium-68 Citrate PET Used in Prostate Cancer
        Recruiting
        • Prostatic Neoplasms
        • Gallium-68 citrate PET
        • Positron Emission Tomography (PET)
        • San Francisco, California
          University of California, San Francisco
        2022-03-28
        Mar 28, 2022
        F
        The Application Value of 18F Prostate-specific Membrane Antigen PET/CT in Prostate Cancer
        Recruiting
        • Prostatic Neoplasms
        • Positron emission tomography/computerized tomography (PET/CT)
        • Xi'an, Shaanxi, China
          First Affiliate Hospital of Xi'an Jiaotong University
        2022-03-23
        Mar 23, 2022
        N
        Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
        Recruiting
        • Prostatic Neoplasms
        • Prostate Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-03-31
          Mar 31, 2022
          M
          Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)
          Active, not recruiting
          • Prostatic Neoplasms
          • Pembrolizumab
          • +4 more
          • Fullerton, California
          • +192 more
          2022-03-30
          Mar 30, 2022
          B
          ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
          Active, not recruiting
          • Prostatic Neoplasms
          • BAY1841788 / darolutamide (ODM-201)
          • +3 more
          • Chandler, Arizona
          • +298 more
          2022-03-30
          Mar 30, 2022
          B
          Treatment Satisfaction With Ra-223 in Japan
          Recruiting
          • Prostatic Neoplasms
          • Radium-223 dichloride (Xofigo, BAY88-8223)
          • Multiple Locations, Japan
            Many Locations
          2022-03-29
          Mar 29, 2022
          V
          Lymphedema After Urologic Surgery
          Recruiting
          • Urinary Bladder Neoplasms
          • +2 more
          • Self-reported lymphedema
          • +2 more
          • Göteborg, Sweden
            Sahlgrenska University Hospital
          2022-03-16
          Mar 16, 2022
          O
          Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
          Recruiting
          • Prostatic Neoplasms
          • Prostatectomy/Surgery
          • Radiotherapy with adjuvant androgen deprivation therapy
          • Aalborg, Denmark
          • +29 more
          2022-03-30
          Mar 30, 2022
          A
          An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
          Available
          • Prostatic Neoplasms
          • Florianopolis, Brazil
          • +19 more
          2022-03-28
          Mar 28, 2022
          H
          Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
          Enrolling by invitation
          • Prostatic Neoplasms
          • multiparametric MRI Diagnostics
          • Herlev, Denmark
            Department of Urology, Herlev University Hospital Herlev
          2022-03-25
          Mar 25, 2022
          A
          An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
          Active, not recruiting
          Has Results
          • Prostatic Neoplasms
          • Phoenix, Arizona
          • +183 more
          2022-03-24
          Mar 24, 2022
          A
          A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
          Active, not recruiting
          Has Results
          • Prostatic Neoplasms
          • Birmingham, Alabama
          • +390 more
          2022-03-24
          Mar 24, 2022
          J
          A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
          Active, not recruiting
          • Prostatic Neoplasms
          • Beijing, China
          • +3 more
          2022-03-24
          Mar 24, 2022
          J
          A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)
          Recruiting
          • Prostatic Neoplasms
          • Los Angeles, California
          • +18 more
          2022-03-24
          Mar 24, 2022
          J
          A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
          Recruiting
          • Prostatic Neoplasms
          • Adenocarcinoma
          • Duarte, California
          • +6 more
          2022-03-24
          Mar 24, 2022